Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$13,549,541
+$2,144,310 QoQ
Shares Held
86,457
+15.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#143
of 1,603 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Waterhouse Canada Inc. holds $797,907,309 across 17 Drug Manufacturers - General names. NVS ranks #9 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,005,440 | $255,351,596 | |
| 2 | LLY |
ELI LILLY & Co
|
192,333 | $230,689,989 | |
| 3 | ABBV |
AbbVie Inc.
|
366,299 | $92,175,480 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
482,201 | $60,921,274 | |
| 5 | MRK |
Merck & Co., Inc.
|
354,395 | $45,539,757 | |
| 6 | AMGN |
Amgen Inc
|
103,282 | $37,400,477 | |
| 7 | AZN |
Astrazeneca PLC
|
137,551 | $26,082,420 | |
| 8 | PFE |
Pfizer Inc
|
673,108 | $16,208,440 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,549,541 | 86,457 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $11,405,231 | 74,666 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $4,001,263 | 29,022 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $3,631,243 | 28,316 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $3,477,222 | 28,735 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $3,195,016 | 28,660 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $530,923 | 5,456 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $638,361 | 5,550 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $592,236 | 5,563 | Shares | Defined | 2024-11-12 | |
| 2024-03-31 | $578,058 | 5,976 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $602,891 | 5,971 | Shares | Defined | 2024-05-10 | |
| 2023-09-30 | $716,992 | 7,039 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $751,375 | 7,446 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $677,120 | 7,360 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $746,807 | 8,232 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $621,229 | 8,173 | Shares | Defined | 2023-11-13 | |
| 2022-06-30 | $883,253 | 10,449 | Shares | Defined | 2023-11-13 | |
| 2022-03-31 | $731,396 | 8,335 | Shares | Defined | 2023-11-13 | |
| 2021-12-31 | $510,999 | 5,842 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||